S&P 500 slips after report on coronavirus drug trial
Reuters Studio
The S&P 500 ended marginally lower on Thursday after a report that an experimental antiviral drug for the coronavirus flopped in..
Stocks Give Up Gains In Late Trading, End Day Slightly In the Red
You might like
Related news coverage
noon adkrjghae.kghalegha
WDEF CBS Chattanooga, TN
Stocks slide as hopes for virus crisis exit fade
Reuters Studio
3.31.20 A Block Coronavirus
WAAY ABC Huntsville, AL